CNO Financial Group, Inc. 5.125
CNO Financial Group, Inc. 5.125 (CNO-PA) Stock Competitors & Peer Comparison
See (CNO-PA) competitors and their performances in Stock Market.
Peer Comparison Table: Insurance - Diversified Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CNO-PA | $18.44 | +0.57% | 3.4B | N/A | N/A | +1.55% |
| BRK-A | $704,760.00 | -0.20% | 1T | 15.14 | $46,535.95 | N/A |
| BRK-B | $469.32 | -0.26% | 1T | 15.12 | $31.04 | N/A |
| AIG-PA | $62.68 | +6.02% | 112.5B | 5.48 | $11.44 | +2.39% |
| AEH | $25.67 | +0.00% | 52.5B | 19.37 | $1.33 | N/A |
| AED | $25.52 | +0.00% | 52.2B | 19.26 | $1.33 | N/A |
| AEB | $25.01 | -0.08% | 51.1B | 18.88 | $1.33 | N/A |
| AIG | $75.14 | -1.56% | 40.3B | 13.83 | $5.43 | +2.39% |
| SLF | $71.53 | +1.12% | 39.6B | 15.96 | $4.48 | +3.62% |
| HIG | $134.45 | -3.70% | 37B | 9.46 | $14.21 | +1.65% |
Stock Comparison
CNO-PA vs BRK-A Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, BRK-A has a market cap of 1T. Regarding current trading prices, CNO-PA is priced at $18.44, while BRK-A trades at $704,760.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas BRK-A's P/E ratio is 15.14. In terms of profitability, CNO-PA's ROE is +0.09%, compared to BRK-A's ROE of +0.10%. Regarding short-term risk, CNO-PA is more volatile compared to BRK-A. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check BRK-A's competition here
CNO-PA vs BRK-B Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, BRK-B has a market cap of 1T. Regarding current trading prices, CNO-PA is priced at $18.44, while BRK-B trades at $469.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas BRK-B's P/E ratio is 15.12. In terms of profitability, CNO-PA's ROE is +0.09%, compared to BRK-B's ROE of +0.10%. Regarding short-term risk, CNO-PA is more volatile compared to BRK-B. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check BRK-B's competition here
CNO-PA vs AIG-PA Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, AIG-PA has a market cap of 112.5B. Regarding current trading prices, CNO-PA is priced at $18.44, while AIG-PA trades at $62.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AIG-PA's P/E ratio is 5.48. In terms of profitability, CNO-PA's ROE is +0.09%, compared to AIG-PA's ROE of +0.07%. Regarding short-term risk, CNO-PA is less volatile compared to AIG-PA. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AIG-PA's competition here
CNO-PA vs AEH Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, AEH has a market cap of 52.5B. Regarding current trading prices, CNO-PA is priced at $18.44, while AEH trades at $25.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AEH's P/E ratio is 19.37. In terms of profitability, CNO-PA's ROE is +0.09%, compared to AEH's ROE of +0.08%. Regarding short-term risk, CNO-PA is more volatile compared to AEH. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check AEH's competition here
CNO-PA vs AED Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, AED has a market cap of 52.2B. Regarding current trading prices, CNO-PA is priced at $18.44, while AED trades at $25.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AED's P/E ratio is 19.26. In terms of profitability, CNO-PA's ROE is +0.09%, compared to AED's ROE of +0.08%. Regarding short-term risk, CNO-PA is more volatile compared to AED. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check AED's competition here
CNO-PA vs AEB Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, AEB has a market cap of 51.1B. Regarding current trading prices, CNO-PA is priced at $18.44, while AEB trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AEB's P/E ratio is 18.88. In terms of profitability, CNO-PA's ROE is +0.09%, compared to AEB's ROE of +0.08%. Regarding short-term risk, CNO-PA is more volatile compared to AEB. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check AEB's competition here
CNO-PA vs AIG Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, AIG has a market cap of 40.3B. Regarding current trading prices, CNO-PA is priced at $18.44, while AIG trades at $75.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AIG's P/E ratio is 13.83. In terms of profitability, CNO-PA's ROE is +0.09%, compared to AIG's ROE of +0.07%. Regarding short-term risk, CNO-PA is less volatile compared to AIG. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AIG's competition here
CNO-PA vs SLF Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, SLF has a market cap of 39.6B. Regarding current trading prices, CNO-PA is priced at $18.44, while SLF trades at $71.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas SLF's P/E ratio is 15.96. In terms of profitability, CNO-PA's ROE is +0.09%, compared to SLF's ROE of +0.15%. Regarding short-term risk, CNO-PA is more volatile compared to SLF. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check SLF's competition here
CNO-PA vs HIG Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, HIG has a market cap of 37B. Regarding current trading prices, CNO-PA is priced at $18.44, while HIG trades at $134.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas HIG's P/E ratio is 9.46. In terms of profitability, CNO-PA's ROE is +0.09%, compared to HIG's ROE of +0.22%. Regarding short-term risk, CNO-PA is less volatile compared to HIG. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check HIG's competition here
CNO-PA vs ACGL Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ACGL has a market cap of 34.3B. Regarding current trading prices, CNO-PA is priced at $18.44, while ACGL trades at $96.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGL's P/E ratio is 8.29. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ACGL's ROE of +0.19%. Regarding short-term risk, CNO-PA is less volatile compared to ACGL. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ACGL's competition here
CNO-PA vs PFG Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, PFG has a market cap of 21.5B. Regarding current trading prices, CNO-PA is priced at $18.44, while PFG trades at $99.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas PFG's P/E ratio is 14.25. In terms of profitability, CNO-PA's ROE is +0.09%, compared to PFG's ROE of +0.10%. Regarding short-term risk, CNO-PA is less volatile compared to PFG. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check PFG's competition here
CNO-PA vs ATH Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ATH has a market cap of 19.8B. Regarding current trading prices, CNO-PA is priced at $18.44, while ATH trades at $83.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH's P/E ratio is 4.42. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ATH's ROE of +0.01%. Regarding short-term risk, CNO-PA is less volatile compared to ATH. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ATH's competition here
CNO-PA vs HIG-PG Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, HIG-PG has a market cap of 18.6B. Regarding current trading prices, CNO-PA is priced at $18.44, while HIG-PG trades at $25.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas HIG-PG's P/E ratio is 3.44. In terms of profitability, CNO-PA's ROE is +0.09%, compared to HIG-PG's ROE of +0.22%. Regarding short-term risk, CNO-PA is more volatile compared to HIG-PG. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check HIG-PG's competition here
CNO-PA vs ACGLP Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ACGLP has a market cap of 15.2B. Regarding current trading prices, CNO-PA is priced at $18.44, while ACGLP trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGLP's P/E ratio is 5.03. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ACGLP's ROE of +0.19%. Regarding short-term risk, CNO-PA is more volatile compared to ACGLP. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check ACGLP's competition here
CNO-PA vs BNT Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, BNT has a market cap of 15.2B. Regarding current trading prices, CNO-PA is priced at $18.44, while BNT trades at $45.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas BNT's P/E ratio is 13.60. In terms of profitability, CNO-PA's ROE is +0.09%, compared to BNT's ROE of +0.05%. Regarding short-term risk, CNO-PA is less volatile compared to BNT. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check BNT's competition here
CNO-PA vs AEG Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, AEG has a market cap of 12.1B. Regarding current trading prices, CNO-PA is priced at $18.44, while AEG trades at $8.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AEG's P/E ratio is 11.30. In terms of profitability, CNO-PA's ROE is +0.09%, compared to AEG's ROE of +0.12%. Regarding short-term risk, CNO-PA is less volatile compared to AEG. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AEG's competition here
CNO-PA vs ACGLO Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ACGLO has a market cap of 11.9B. Regarding current trading prices, CNO-PA is priced at $18.44, while ACGLO trades at $20.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGLO's P/E ratio is 4.36. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ACGLO's ROE of +0.19%. Regarding short-term risk, CNO-PA is less volatile compared to ACGLO. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ACGLO's competition here
CNO-PA vs EQH Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, EQH has a market cap of 11.6B. Regarding current trading prices, CNO-PA is priced at $18.44, while EQH trades at $41.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas EQH's P/E ratio is -8.51. In terms of profitability, CNO-PA's ROE is +0.09%, compared to EQH's ROE of -1.52%. Regarding short-term risk, CNO-PA is less volatile compared to EQH. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check EQH's competition here
CNO-PA vs ORI Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ORI has a market cap of 9.8B. Regarding current trading prices, CNO-PA is priced at $18.44, while ORI trades at $40.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ORI's P/E ratio is 10.85. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ORI's ROE of +0.17%. Regarding short-term risk, CNO-PA is less volatile compared to ORI. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ORI's competition here
CNO-PA vs ACGLN Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ACGLN has a market cap of 6.4B. Regarding current trading prices, CNO-PA is priced at $18.44, while ACGLN trades at $17.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGLN's P/E ratio is 3.68. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ACGLN's ROE of +0.19%. Regarding short-term risk, CNO-PA is more volatile compared to ACGLN. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check ACGLN's competition here
CNO-PA vs EQH-PA Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, EQH-PA has a market cap of 6B. Regarding current trading prices, CNO-PA is priced at $18.44, while EQH-PA trades at $20.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas EQH-PA's P/E ratio is 5.29. In terms of profitability, CNO-PA's ROE is +0.09%, compared to EQH-PA's ROE of -1.52%. Regarding short-term risk, CNO-PA is less volatile compared to EQH-PA. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check EQH-PA's competition here
CNO-PA vs UNMA Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, UNMA has a market cap of 5.4B. Regarding current trading prices, CNO-PA is priced at $18.44, while UNMA trades at $23.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas UNMA's P/E ratio is 4.92. In terms of profitability, CNO-PA's ROE is +0.09%, compared to UNMA's ROE of +0.07%. Regarding short-term risk, CNO-PA is more volatile compared to UNMA. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check UNMA's competition here
CNO-PA vs ESGRP Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ESGRP has a market cap of 5.3B. Regarding current trading prices, CNO-PA is priced at $18.44, while ESGRP trades at $20.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ESGRP's P/E ratio is -13.72. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ESGRP's ROE of +0.03%. Regarding short-term risk, CNO-PA is more volatile compared to ESGRP. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check ESGRP's competition here
CNO-PA vs ATH-PE Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ATH-PE has a market cap of 5.1B. Regarding current trading prices, CNO-PA is priced at $18.44, while ATH-PE trades at $25.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PE's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ATH-PE's ROE of +0.01%. Regarding short-term risk, CNO-PA is more volatile compared to ATH-PE. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check ATH-PE's competition here
CNO-PA vs ATH-PC Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ATH-PC has a market cap of 5.1B. Regarding current trading prices, CNO-PA is priced at $18.44, while ATH-PC trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PC's P/E ratio is 3.14. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ATH-PC's ROE of +0.01%. Regarding short-term risk, CNO-PA is more volatile compared to ATH-PC. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check ATH-PC's competition here
CNO-PA vs ESGR Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ESGR has a market cap of 5B. Regarding current trading prices, CNO-PA is priced at $18.44, while ESGR trades at $337.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ESGR's P/E ratio is 10.83. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ESGR's ROE of +0.03%. Regarding short-term risk, CNO-PA is more volatile compared to ESGR. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check ESGR's competition here
CNO-PA vs ESGRO Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ESGRO has a market cap of 5B. Regarding current trading prices, CNO-PA is priced at $18.44, while ESGRO trades at $19.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ESGRO's P/E ratio is -12.87. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ESGRO's ROE of +0.03%. Regarding short-term risk, CNO-PA is more volatile compared to ESGRO. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check ESGRO's competition here
CNO-PA vs EQH-PC Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, EQH-PC has a market cap of 4.9B. Regarding current trading prices, CNO-PA is priced at $18.44, while EQH-PC trades at $16.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas EQH-PC's P/E ratio is 4.36. In terms of profitability, CNO-PA's ROE is +0.09%, compared to EQH-PC's ROE of -1.52%. Regarding short-term risk, CNO-PA is less volatile compared to EQH-PC. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check EQH-PC's competition here
CNO-PA vs ATH-PA Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ATH-PA has a market cap of 4.8B. Regarding current trading prices, CNO-PA is priced at $18.44, while ATH-PA trades at $24.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PA's P/E ratio is 3.03. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ATH-PA's ROE of +0.01%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PA. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ATH-PA's competition here
CNO-PA vs ATH-PB Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ATH-PB has a market cap of 3.9B. Regarding current trading prices, CNO-PA is priced at $18.44, while ATH-PB trades at $19.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PB's P/E ratio is 2.42. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ATH-PB's ROE of +0.01%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PB. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ATH-PB's competition here
CNO-PA vs ATH-PD Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ATH-PD has a market cap of 3.4B. Regarding current trading prices, CNO-PA is priced at $18.44, while ATH-PD trades at $16.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PD's P/E ratio is 2.07. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ATH-PD's ROE of +0.01%. Regarding short-term risk, CNO-PA is more volatile compared to ATH-PD. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check ATH-PD's competition here
CNO-PA vs FIHL Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, FIHL has a market cap of 2.2B. Regarding current trading prices, CNO-PA is priced at $18.44, while FIHL trades at $20.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas FIHL's P/E ratio is 9.93. In terms of profitability, CNO-PA's ROE is +0.09%, compared to FIHL's ROE of +0.09%. Regarding short-term risk, CNO-PA is less volatile compared to FIHL. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check FIHL's competition here
CNO-PA vs GSHD Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, GSHD has a market cap of 1.7B. Regarding current trading prices, CNO-PA is priced at $18.44, while GSHD trades at $48.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas GSHD's P/E ratio is 42.33. In terms of profitability, CNO-PA's ROE is +0.09%, compared to GSHD's ROE of -0.30%. Regarding short-term risk, CNO-PA is less volatile compared to GSHD. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check GSHD's competition here
CNO-PA vs RZC Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, RZC has a market cap of 1.7B. Regarding current trading prices, CNO-PA is priced at $18.44, while RZC trades at $25.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas RZC's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.09%, compared to RZC's ROE of +0.09%. Regarding short-term risk, CNO-PA is less volatile compared to RZC. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check RZC's competition here
CNO-PA vs XZO Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, XZO has a market cap of 1.5B. Regarding current trading prices, CNO-PA is priced at $18.44, while XZO trades at $16.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas XZO's P/E ratio is 17.05. In terms of profitability, CNO-PA's ROE is +0.09%, compared to XZO's ROE of +0.25%. Regarding short-term risk, CNO-PA is less volatile compared to XZO. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check XZO's competition here
CNO-PA vs IGIC Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, IGIC has a market cap of 1.2B. Regarding current trading prices, CNO-PA is priced at $18.44, while IGIC trades at $26.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas IGIC's P/E ratio is 9.10. In terms of profitability, CNO-PA's ROE is +0.09%, compared to IGIC's ROE of +0.19%. Regarding short-term risk, CNO-PA is less volatile compared to IGIC. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check IGIC's competition here
CNO-PA vs AIZN Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, AIZN has a market cap of 975.6M. Regarding current trading prices, CNO-PA is priced at $18.44, while AIZN trades at $19.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AIZN's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.09%, compared to AIZN's ROE of +0.16%. Regarding short-term risk, CNO-PA is less volatile compared to AIZN. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AIZN's competition here
CNO-PA vs ARGD Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ARGD has a market cap of 874.2M. Regarding current trading prices, CNO-PA is priced at $18.44, while ARGD trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ARGD's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ARGD's ROE of +0.02%. Regarding short-term risk, CNO-PA is more volatile compared to ARGD. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check ARGD's competition here
CNO-PA vs WDH Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, WDH has a market cap of 607.7M. Regarding current trading prices, CNO-PA is priced at $18.44, while WDH trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas WDH's P/E ratio is 7.64. In terms of profitability, CNO-PA's ROE is +0.09%, compared to WDH's ROE of +0.11%. Regarding short-term risk, CNO-PA is less volatile compared to WDH. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check WDH's competition here
CNO-PA vs YB Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, YB has a market cap of 128.5M. Regarding current trading prices, CNO-PA is priced at $18.44, while YB trades at $16.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas YB's P/E ratio is 4.16. In terms of profitability, CNO-PA's ROE is +0.09%, compared to YB's ROE of +1.89%. Regarding short-term risk, CNO-PA is less volatile compared to YB. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check YB's competition here
CNO-PA vs FGNX Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, FGNX has a market cap of 54.2M. Regarding current trading prices, CNO-PA is priced at $18.44, while FGNX trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas FGNX's P/E ratio is -0.26. In terms of profitability, CNO-PA's ROE is +0.09%, compared to FGNX's ROE of -0.53%. Regarding short-term risk, CNO-PA is less volatile compared to FGNX. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check FGNX's competition here
CNO-PA vs FGFPP Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, FGFPP has a market cap of 25.9M. Regarding current trading prices, CNO-PA is priced at $18.44, while FGFPP trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas FGFPP's P/E ratio is -7.69. In terms of profitability, CNO-PA's ROE is +0.09%, compared to FGFPP's ROE of -0.53%. Regarding short-term risk, CNO-PA is less volatile compared to FGFPP. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check FGFPP's competition here
CNO-PA vs FGF Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, FGF has a market cap of 4.7M. Regarding current trading prices, CNO-PA is priced at $18.44, while FGF trades at $3.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas FGF's P/E ratio is -0.29. In terms of profitability, CNO-PA's ROE is +0.09%, compared to FGF's ROE of -0.54%. Regarding short-term risk, CNO-PA is less volatile compared to FGF. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check FGF's competition here
CNO-PA vs IGICW Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, IGICW has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $18.44, while IGICW trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas IGICW's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.09%, compared to IGICW's ROE of +0.19%. Regarding short-term risk, CNO-PA is less volatile compared to IGICW. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check IGICW's competition here
CNO-PA vs WTREP Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, WTREP has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $18.44, while WTREP trades at $25.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas WTREP's P/E ratio is 1.35. In terms of profitability, CNO-PA's ROE is +0.09%, compared to WTREP's ROE of +0.00%. Regarding short-term risk, CNO-PA is more volatile compared to WTREP. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check WTREP's competition here
CNO-PA vs ANAT Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, ANAT has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $18.44, while ANAT trades at $188.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ANAT's P/E ratio is 6.73. In terms of profitability, CNO-PA's ROE is +0.09%, compared to ANAT's ROE of +0.10%. Regarding short-term risk, CNO-PA is more volatile compared to ANAT. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check ANAT's competition here
CNO-PA vs HGH Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, HGH has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $18.44, while HGH trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas HGH's P/E ratio is -3.09. In terms of profitability, CNO-PA's ROE is +0.09%, compared to HGH's ROE of +0.02%. Regarding short-term risk, CNO-PA is more volatile compared to HGH. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check HGH's competition here
CNO-PA vs AMIC Comparison April 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.4B. In comparison, AMIC has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $18.44, while AMIC trades at $24.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AMIC's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.09%, compared to AMIC's ROE of +0.04%. Regarding short-term risk, CNO-PA is more volatile compared to AMIC. This indicates potentially higher risk in terms of short-term price fluctuations for CNO-PA.Check AMIC's competition here